Amniotics’ COO invited speaker at global ATMP congress
May 15, 2023
Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announces that the company Chief Operating Officer (COO), Jan Talts will speak at the “4th Global Bioprocessing, Bioanalytics & ATMP Manufacturing Congress”, taking place in Dublin 15-16 May 2023.
The title of the talk is “Biological raw material sourcing for an early stage ATMP and considerations for later clinical stage development”. This conference provides an interactive networking forum for bioprocessing experts to examine novel solutions and strategies that will improve the efficiency of biotherapeutic development.